课题基金 / 基金详情

IDENTIFICATION OF CASPASE-2 SUBSTRATES

IDENTIFICATION OF CASPASE-2 SUBSTRATES
CASPASE-2 底物的鉴定
批准号:
8363812
负责人:
JAMES A WELLS
金额:
$0.97万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-05-31

项目摘要

项目成果

JAMES A WELLS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Caspase-2 is the most conserved caspase across different species. It has been reported that Caspase-2 is involved in oocyte death, DNA damage, heat shock-induced death and mitotic catastrophe. However, the exact role of caspase-2 in these biological events is not clear yet due to the lack of knowledge of the substrates of caspase-2. My project is to identify caspase-2 substrates using the established "degradomics" techniques. First, I will treat healthy Jurkat extracts with recombinant active caspase-2. Protein N-terminus in the sample will be labeled, enriched and sequenced by mass spectrometry to identify caspase-2 cleavage. Second, I will use a caspase-2 inducible system to induce endogenous substrate cleavage. Cell extracts will also be labeled, enriched and sequenced by mass spectrometry. Data from both experiments will be compared and integrated to identify caspase-2 substrates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution
Discovering how oncogenes remodel the surfaceome of cells
国内基金
海外基金
中药活性成分土木香内酯靶向 TXNL2 通过caspase-3/GSDME 介导的细胞焦亡抗未分化甲状腺癌的机制研究
  • 批准号:
    ZCLQN26H2801
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    温庆良
  • 依托单位:
壮骨止痛胶囊通过NLRP3/Caspase-1/GSDMD信号通路调控神经肽介导PMOP大鼠脑-肠-骨轴的机制研究
  • 批准号:
    2026JJ81070
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    陈沙
  • 依托单位:
骨痹汤调控NLRP3/ASC/Caspase-1介导的细胞焦亡治疗膝骨关节炎的作用及机制研究
  • 批准号:
    2026JJ80380
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    郑艳艳
  • 依托单位:
TIRAP调控NLRP3/Caspase-1/GSDMD通路诱导KOA软骨细胞焦亡机制的研究